| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.10. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 24.09. | Shuttle Pharmaceuticals Holdings, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| SHUTTLE PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 11.09. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 02.09. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.08. | Shuttle Pharmaceuticals fails to meet Nasdaq filing requirements | 5 | Investing.com | ||
| 28.08. | Shuttle Pharmaceuticals verfehlt Meldefrist der NASDAQ | 5 | Investing.com Deutsch | ||
| 28.08. | Shuttle Pharmaceuticals gets Nasdaq notice after missing 10-Q filing deadline | 1 | Seeking Alpha | ||
| 17.08. | Shuttle Pharmaceuticals Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| 26.06. | United Dogecoin erwirbt Mining-Flotte und strebt Betriebsaufnahme an | 15 | Investing.com Deutsch | ||
| 26.06. | United Dogecoin purchases mining fleet, targets operations start | 1 | Investing.com | ||
| 26.06. | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site | 443 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - June 26, 2026) - United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts recently acquired by Shuttle... ► Artikel lesen | |
| 25.06. | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Advances Data Centre and Power Infrastructure Strategy to Support DOGE Mining and AI Hosting | 716 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - June 25, 2026) - United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining and digital infrastructure company driven by industry experts... ► Artikel lesen | |
| 11.06. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.06. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time | 760 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - June 9, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), the owner of Molecule.ai, an artificial intelligence... ► Artikel lesen | |
| 27.05. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 14.05. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs | 1.093 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - May 14, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle" or the "Company") today announced the closing (the "Closing") of its previously... ► Artikel lesen | |
| 14.05. | Shuttle Pharma completes merger with United Dogecoin | 2 | Investing.com | ||
| 01.05. | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation | 977 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - May 1, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin... ► Artikel lesen | |
| 30.04. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner | 1.056 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - April 30, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin... ► Artikel lesen | |
| 26.03. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows | 730 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - March 26, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), today announced a major advancement to its... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QUANTUM BIOPHARMA | 2,064 | +4,24 % | Quantum BioPharma Signs Contract with Thermo Fisher Scientific's Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis | TORONTO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) ("Quantum BioPharma"), a biopharmaceutical company focused on developing innovative therapies and technologies... ► Artikel lesen | |
| JAGUAR HEALTH | 0,884 | 0,00 % | Jaguar Health, Inc.: CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai | Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and short bowel syndrome (SBS-IF) for crofelemer powder... ► Artikel lesen | |
| LIPOCINE | 1,440 | -0,69 % | Lipocine Inc.: Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression | Study informed by encouraging exploratory efficacy findings and a favorable safety profile in the prior Phase 3 trial
Approximately 120 participants with severe... ► Artikel lesen | |
| THERAPEUTICSMD | 1,550 | -1,90 % | TherapeuticsMD, Inc. - 10-Q, Quarterly Report | ||
| ALLARITY THERAPEUTICS | 0,978 | +11,27 % | Allarity Therapeutics, Inc. - 8-K, Current Report | ||
| EXICURE | 0,885 | -1,67 % | Exicure, Inc.: Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance | WILMINGTON, Del., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) ("Exicure" or the "Company") today announced that it expects to issue 172,058 shares of its common stock to GPCR Therapeutics... ► Artikel lesen | |
| COSMOS HEALTH | 0,282 | +2,47 % | Cosmos Health Inc.: Cosmos Health's U.S. Active Subscriptions Surpass 12,000, Up 92% in Two Weeks | Active subscriptions up 92%: 12,050 active U.S. subscriptions as of October 28, 2026, up from 6,287 on October 14, 2026Monthly subscription value up 94%: $1,787,585 at standard renewal pricing as of... ► Artikel lesen | |
| 60 DEGREES PHARMACEUTICALS | 0,898 | 0,00 % | 60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome | ||
| SUNSHINE BIOPHARMA | 2,730 | 0,00 % | Sunshine Biopharma Inc.: Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing | FORT LAUDERDALE, FL / ACCESS Newswire / October 22, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company specializing in generic and specialty prescription medications... ► Artikel lesen | |
| CELLYAN BIOTECHNOLOGY | 1,910 | 0,00 % | Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period | HONG KONG, July 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply... ► Artikel lesen | |
| BAYER | 50,02 | +5,46 % | Aktien Frankfurt Ausblick: Dax stabilisiert sich | FRANKFURT (dpa-AFX) - Der Dax steuert nach der schwachen Vorwoche am Montag auf eine Stabilisierung zu. Eine Stunde vor Handelsbeginn signalisierte der X-Dax für den deutschen Leitindex ein Plus von... ► Artikel lesen | |
| TEVA PHARMACEUTICAL INDUSTRIES | 40,640 | 0,00 % | Teva To Discontinue TOPAS-MSA Study In Adults With Multiple System Atrophy | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries (TEVA),
announced that it will discontinue the Phase 2 TOPAS-MSA study evaluating emrusolmin... ► Artikel lesen | |
| MERCK KGAA | 150,00 | +0,67 % | BARCLAYS stuft MERCK KGAA auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Merck KGaA von 150 auf 160 Euro angehoben, aber die Einstufung auf "Equal Weight" belassen. Analyst Charles Pitman-King... ► Artikel lesen | |
| PFIZER | 27,445 | +0,49 % | JEFFERIES stuft PFIZER INC auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Pfizer mit einem Kursziel von 36 US-Dollar auf "Buy" belassen. Akash Tewari bezieht sich in seiner am Montag vorliegenden... ► Artikel lesen | |
| NOVO NORDISK | 36,100 | +0,94 % | Pharmaaktien mit Zukunft - Bayer, BioNxt Solutions, Novo Nordisk füllen ihre Pipelines | Kein Pharmakonzern lebt ewig von seinen Bestsellern. Irgendwann läuft der Patentschutz aus, Nachahmer drängen in den Markt und die Margen schrumpfen. Wer dann keinen Nachschub hat, sitzt auf dem Trockenen.... ► Artikel lesen |